Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis

Expert Opin Drug Metab Toxicol. 2019 Aug;15(8):615-618. doi: 10.1080/17425255.2019.1648432. Epub 2019 Jul 30.

Authors

Christine Sekaggya-Wiltshire¹, Kelly E Dooley²

Affiliations

¹ a Infectious Diseases Institute, Makerere University College of Health Sciences , Kampala , Uganda.
² b Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore , USA.

PMID: 31339806
DOI: 10.1080/17425255.2019.1648432

No abstract available

Keywords: Rifamycins; pharmacodynamics; pharmacokinetics; tuberculosis.

Publication types

Editorial

MeSH terms

Antibiotics, Antitubercular / administration & dosage*
Antibiotics, Antitubercular / pharmacokinetics
Antibiotics, Antitubercular / pharmacology
Dose-Response Relationship, Drug
Drug Interactions
Humans
Rifamycins / administration & dosage*
Rifamycins / pharmacokinetics
Rifamycins / pharmacology
Tuberculosis / drug therapy*

Substances

Antibiotics, Antitubercular
Rifamycins